DBVT DBV Technologies S.A.
DBV Technologies S.A. (DBVT) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $9.9M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Mohideen Pharis | Chief Medical Officer | Sell | 464 | $2.70 | $1.3K | 144,531 −0.3% of holding | |
| Mohideen Pharis | Chief Medical Officer | Sell | 534 | $4.86 | $2.6K | 144,995 −0.4% of holding | |
| Sell | 1,292,103 | $4.19 | $5.4M | 7,303,369 −15% of holding | |||
| 2 fills | Sell | 2,076,990 | $4.85 | $10.1M | 8,635,472 −19.4% of holding | ||
| Mohideen Pharis | Chief Medical Officer | Sell | 1,624 | $2.77 | $4.5K | 101,529 −1.6% of holding | |
| Mohideen Pharis | Chief Medical Officer | Sell | 6,496 | $2.88 | $18.7K | 103,153 −5.9% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.